392 related articles for article (PubMed ID: 31817878)
21. The unique regulation of brain cytochrome P450 2 (CYP2) family enzymes by drugs and genetics.
Miksys S; Tyndale RF
Drug Metab Rev; 2004 May; 36(2):313-33. PubMed ID: 15237857
[TBL] [Abstract][Full Text] [Related]
22. Characterization of xenobiotic-metabolizing cytochrome P450 (CYP) forms in ringed and grey seals from the Baltic Sea and reference sites.
Nyman M; Raunio H; Taavitsainen P; Pelkonen O
Comp Biochem Physiol C Toxicol Pharmacol; 2001 Jan; 128(1):99-112. PubMed ID: 11166678
[TBL] [Abstract][Full Text] [Related]
23. Modeling of interactions between xenobiotics and cytochrome P450 (CYP) enzymes.
Raunio H; Kuusisto M; Juvonen RO; Pentikäinen OT
Front Pharmacol; 2015; 6():123. PubMed ID: 26124721
[TBL] [Abstract][Full Text] [Related]
24. Expression and regulation of xenobiotic-metabolizing cytochrome P450 (CYP) enzymes in human lung.
Hukkanen J; Pelkonen O; Hakkola J; Raunio H
Crit Rev Toxicol; 2002 Sep; 32(5):391-411. PubMed ID: 12389869
[TBL] [Abstract][Full Text] [Related]
25. Extracellular Vesicles in HIV, Drug Abuse, and Drug Delivery.
Kumar S; El-Hage N; Batrakova E
J Neuroimmune Pharmacol; 2020 Sep; 15(3):387-389. PubMed ID: 32696265
[TBL] [Abstract][Full Text] [Related]
26. Molecular mechanisms of the microsomal mixed function oxidases and biological and pathological implications.
Cederbaum AI
Redox Biol; 2015; 4():60-73. PubMed ID: 25498968
[TBL] [Abstract][Full Text] [Related]
27. Effects of cytochrome P450 inhibitors on peroxidase activity.
Martinkova M; Kubickova B; Stiborova M
Neuro Endocrinol Lett; 2012; 33 Suppl 3():33-40. PubMed ID: 23353841
[TBL] [Abstract][Full Text] [Related]
28. Expression of xenobiotic-metabolizing CYPs in human pulmonary tissue.
Raunio H; Hakkola J; Hukkanen J; Lassila A; Päivärinta K; Pelkonen O; Anttila S; Piipari R; Boobis A; Edwards RJ
Exp Toxicol Pathol; 1999 Jul; 51(4-5):412-7. PubMed ID: 10445407
[TBL] [Abstract][Full Text] [Related]
29. Differences in immunohistochemical expression of xenobiotic-metabolizing enzymes between normal pancreas, chronic pancreatitis and pancreatic cancer.
Standop J; Schneider M; Ulrich A; Büchler MW; Pour PM
Toxicol Pathol; 2003; 31(5):506-13. PubMed ID: 14692619
[TBL] [Abstract][Full Text] [Related]
30. FAD-dependent enzymes involved in the metabolic oxidation of xenobiotics.
Strolin Benedetti M
Ann Pharm Fr; 2011 Jan; 69(1):45-52. PubMed ID: 21296217
[TBL] [Abstract][Full Text] [Related]
31. Short-term hepatic effects of depleted uranium on xenobiotic and bile acid metabolizing cytochrome P450 enzymes in the rat.
Guéguen Y; Souidi M; Baudelin C; Dudoignon N; Grison S; Dublineau I; Marquette C; Voisin P; Gourmelon P; Aigueperse J
Arch Toxicol; 2006 Apr; 80(4):187-95. PubMed ID: 16231126
[TBL] [Abstract][Full Text] [Related]
32. Potential Roles of Extracellular Vesicles as Biomarkers and a Novel Treatment Approach in Multiple Sclerosis.
Gutiérrez-Fernández M; de la Cuesta F; Tallón A; Cuesta I; Fernández-Fournier M; Laso-García F; Gómez-de Frutos MC; Díez-Tejedor E; Otero-Ortega L
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445717
[TBL] [Abstract][Full Text] [Related]
33. Xenobiotic-metabolizing cytochromes P450 in ontogeny: evolving perspective.
Choudhary D; Jansson I; Sarfarazi M; Schenkman JB
Drug Metab Rev; 2004 Oct; 36(3-4):549-68. PubMed ID: 15554235
[TBL] [Abstract][Full Text] [Related]
34. Expression of xenobiotic-metabolizing cytochrome P450 forms in human adult and fetal liver.
Hakkola J; Pasanen M; Purkunen R; Saarikoski S; Pelkonen O; Mäenpää J; Rane A; Raunio H
Biochem Pharmacol; 1994 Jul; 48(1):59-64. PubMed ID: 8043031
[TBL] [Abstract][Full Text] [Related]
35. Functional Analysis of the Unique Cytochrome P450 of the Liver Fluke Opisthorchis felineus.
Pakharukova MY; Vavilin VA; Sripa B; Laha T; Brindley PJ; Mordvinov VA
PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004258. PubMed ID: 26625139
[TBL] [Abstract][Full Text] [Related]
36. Extracellular vesicles in liver disease and beyond.
Morán L; Cubero FJ
World J Gastroenterol; 2018 Oct; 24(40):4519-4526. PubMed ID: 30386101
[TBL] [Abstract][Full Text] [Related]
37. Cytochrome P450 pharmacogenetics and cancer.
Rodriguez-Antona C; Ingelman-Sundberg M
Oncogene; 2006 Mar; 25(11):1679-91. PubMed ID: 16550168
[TBL] [Abstract][Full Text] [Related]
38. Phosphorylation of cytochromes P450: first discovery of a posttranslational modification of a drug-metabolizing enzyme.
Oesch-Bartlomowicz B; Oesch F
Biochem Biophys Res Commun; 2005 Dec; 338(1):446-9. PubMed ID: 16137648
[TBL] [Abstract][Full Text] [Related]
39. Extracellular vesicles: Novel mediator for cell to cell communications in liver pathogenesis.
Devhare PB; Ray RB
Mol Aspects Med; 2018 Apr; 60():115-122. PubMed ID: 29122679
[TBL] [Abstract][Full Text] [Related]
40. Oxidation of 3-aminobenzanthrone, a human metabolite of carcinogenic environmental pollutant 3-nitrobenzanthrone, by cytochromes P450 - similarity between human and rat enzymes.
Mizerovska J; Dracinska H; Arlt VM; Schmeiser HH; Frei E; Stiborova M
Neuro Endocrinol Lett; 2009; 30 Suppl 1():52-9. PubMed ID: 20027145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
